News Center
News Center
Disseminate company news and understand industry trends

Positive Phase III Trial Results for Novel Alzheimer's Drug Lecanemab-Prodrome to be Presented at ECNP

Published Time:

2025-10-16

Full positive results from the Phase III clinical trial of "Lecanemab-Prodrome," targeting early-stage Alzheimer's disease, are scheduled for presentation at the European College of Neuropsychopharmacology (ECNP) Congress in late September 2025. The data is anticipated to show significant slowing of cognitive decline in prodromal patients.

Related News

Major Pharma Players Forge Alliance for AI-Driven Drug Discovery, Announcement Expected in Early Q3

2025-10-16

Japan's MHLW Proposes New Guidelines to Accelerate Review of Complex Generic Drugs

2025-10-16

First Generic Versions of Popular GLP-1 Agonist Expected to Launch in Q3 2025 Following Patent Expiry

2025-10-16

Positive Phase III Trial Results for Novel Alzheimer's Drug Lecanemab-Prodrome to be Presented at ECNP

2025-10-16

CPhI Worldwide 2025 to Take Place in Frankfurt, Highlighting Pharma Innovation and Global Supply Chain

2025-10-16

The 93rd API China Concludes Successfully in Chongqing, Driving Western China Pharma Development

2025-10-16

Share to

Return to List
Wanzhen Pharmaceutical

Our company is committed to the development and research of medical technology, closely cooperating with key laboratories of surrounding universities, using many years of market resources, striving to improve the independent innovation ability of enterprises, keeping up with the development trend of the international pharmaceutical market, and constantly providing source of power for the development of enterprises.

Contact Information

Tel

025-84676418、025-84676428

Email

wll@jswz-pharm.com

Address

D6-1104, Jiangsu Life Science and Technology Innovation Park, No. 9 Weidi Road, Qixia District, Nanjing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

025-84676418
025-84676428
wll@jswz-pharm.com
TOP

Copyright © 2025 Jiangsu Wanzhen Pharmaceutical Technology Co., Ltd.

Powered by:300.cn | SEO